Literature DB >> 24885026

Schmallenberg virus antibody persistence in adult cattle after natural infection and decay of maternal antibodies in calves.

Armin R W Elbers1, Norbert Stockhofe-Zurwieden, Wim H M van der Poel.   

Abstract

BACKGROUND: Schmallenberg virus (SBV) has swept through the major part of Europe in the period 2011-2013. A vaccine against SBV has been developed and may be a possible preventive instrument against infection. Presently, there is no data available to refute the assumption that natural SBV infection results in long-term immunity. In that respect, it is of interest to know how long (protecting) virus-neutralizing antibodies are present in naturally infected animals. New-born calves acquire passive immunity from their dams by ingestion and absorption of antibodies present in colostrum, which can block the production of serum antibodies when vaccine is administered to calves with maternally derived antibodies. In that respect, it is useful to know how long it takes for maternal antibodies against SBV to disappear in young animals born from infected dams.
RESULTS: Longitudinal whole-herd serological monitoring using virus neutralization test (VNT) indicated that 80% of adult dairy cows still had measurable antibodies against SBV at least 24 months after the estimated introduction of the virus into the herd. Median 2Log VNT titer of the adult dairy cows (≥1 year) dropped from 8.6 to 5.6 in a period of 17 months. Median 2Log VNT maternal antibodies titers of calves sampled within 30 days after birth was 8. Calves lost their maternally-derived antibodies after 5-6 months. There was a definite positive relationship between the VNT titer of the dam and the VNT titer of the corresponding calf (age ≤ 30 days) of dam-calf combinations sampled on the same day: the higher the VNT titer of the dam, the higher the VNT titer (maternal antibodies) of the calf.
CONCLUSIONS: Our field data support the assumption that natural SBV infection in adult cows results in persistence of specific antibodies for at least two years. Based on the observed decay of maternally-derived antibodies in calves, it is presumed safe to vaccinate calves against SBV at an age of approximately 6 months.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24885026      PMCID: PMC4013805          DOI: 10.1186/1746-6148-10-103

Source DB:  PubMed          Journal:  BMC Vet Res        ISSN: 1746-6148            Impact factor:   2.741


Background

Schmallenberg virus (SBV), a novel Orthobunyavirus, has swept through the major part of Europe in the period 2011–2013, reaching as far North as Finland, Turkey in the East, and Spain in the South [1,2]. A serological survey of blood samples, collected in the period November 2011 – January 2012, from a representative sample of cattle in the Netherlands indicated a high seroprevalence of antibodies against SBV [3]. So far, the impression is that the clinical impact of the disease on ruminant livestock is limited [1]. A vaccine against SBV has been developed [4] and may be a possible preventive instrument against infection. Presently, there is no data available to refute the assumption that natural SBV infection results in long-term immunity [1], as was seen earlier with natural infection of cattle with bluetongue virus serotype 8 [5]. In that respect, it is of interest to know how long (protecting) virus-neutralizing antibodies are present in naturally infected animals. Newborn calves acquire passive immunity from their dams by ingestion and absorption of antibodies present in colostrum. The estimated duration and benefit of this passively derived humoral immunity can vary greatly depending on the colostrum production (quantity and quality) and the quantity of antibody ingested and absorbed [6]. Passive immunity can block the production of serum antibodies when vaccine is administered to calves with maternally-derived antibodies [7]. In that respect, it is useful to know how long it takes for maternal antibodies against SBV to disappear in young animals born from infected dams. To examine the development and the course of neutralizing-antibodies against SBV over time, in a dairy herd in the eastern part of the Netherlands where SBV RNA was detected in a high proportion of Culicoides caught in the autumn of 2011 [8], all animals were blood-sampled five times in a 17-month period, and tested for SBV specific neutralizing antibodies.

Results and discussion

At the 1st sampling (19 April 2012), all adult cows (≥1year of age) tested seropositive, only four calves (6 months of age) tested seronegative. Seventeen months later at the fifth sampling (23 September 2013), 80% of the adult cows still tested seropositive, while only 9% of the cows < 1year of age tested seropositive (Table 1). Median 2Log VNT titer of the adult cows dropped from 8.6 (range: 5.5 – 9.5) to 5.6 (range: 2 – 8) in a period of 17 months (Figure 1). It can be assumed that the adult cows became infected around the time that SBV RNA was detected for the first time in Culicoides biting midges caught at this dairy farm on 14 September 2011 [8]. This means that at least 24months after natural infection, animals most likely were protected against re-infection.
Table 1

Distribution of cows with a Log virus neutralization test titer ≥ 3 by sampling date and age category

Sampling dateTotal number of cowsNumber of cows ≥ 1yearNumber of cows ≥ 1year with 2 Log VNT titer ≥ 3Number of cows < 1 yearNumber of cows < 1year with 2 Log VNT titer ≥ 3
19 Apr 2012
108
87
87 (100%)
21
17 (81%)
17 Sept 2012
108
89
89 (100%)
19
19 (100%)
9 Dec 2012
110
89
88 (99%)
21
16 (76%)
23 Apr 2013
116
86
84 (98%)
30
15 (50%)
23 Sept 20131098770 (80%)222 (9%)
Figure 1

Distribution of virus neutralization test (VNT) antibody titers ( Log-scale) against Schmallenberg virus in dairy cattle ≥ 1 year of age by date of sampling, summarized by a box and whisker plot (the central line in the box plot indicates the median of the data, while the edges of the box indicate the 25th and 75th percentiles; extending from the box are whiskers, the top whisker expands to the 90th percentile and the bottom whisker to the 10th percentile; beyond the whiskers are observations that are relatively far from the median).

Distribution of cows with a Log virus neutralization test titer ≥ 3 by sampling date and age category Distribution of virus neutralization test (VNT) antibody titers ( Log-scale) against Schmallenberg virus in dairy cattle ≥ 1 year of age by date of sampling, summarized by a box and whisker plot (the central line in the box plot indicates the median of the data, while the edges of the box indicate the 25th and 75th percentiles; extending from the box are whiskers, the top whisker expands to the 90th percentile and the bottom whisker to the 10th percentile; beyond the whiskers are observations that are relatively far from the median). Eleven heifers seroconverted (seronegative in April 2012 and high VNT-titers (2Log VNT titer ≥ 6) in September 2012) and one dairy cow seroconverted between the September and December 2012 samplings. The low rate of seroconversions matched with a significantly lower (six times) proportion of SBV-infected Culicoides observed in 2012 compared to 2011 [9], and it can be assumed that there was a much lower level of SBV-circulation in the area in 2012 compared to 2011. Calves that were bled ≤ 30 days after birth had a median 2Log VNT titer of 8 (range: 6.5 - 9.5) and became seronegative (2Log VNT titer < 3) within 5–6 months (Figure 2). The presence of maternally-derived antibodies may hamper the effective response to vaccination. Therefore, it is important to consider the age at which the calves lose their maternal antibody, previous to starting a vaccination campaign. There are sparse reports on the course of decay of maternal antibodies against Orthobunyaviruses in ruminants. Tsutsui et al. [10] showed that dairy calves lost their maternally derived antibodies against Akabane virus at an age of approximately 4 months, while Grimstad et al. [11] showed that young white-tailed deer lost their maternal antibodies against Jamestown Canyon virus at an age of 5–6 months. Our results seem to be in range with the above-mentioned studies. To achieve an effective response to vaccination it can be advised to vaccinate calves at an age of at least 6 months.
Figure 2

Virus neutralization test (VNT) antibody titers against Schmallenberg virus of 25 calves by age at sampling (based on 2–3 samplings per calf).

Virus neutralization test (VNT) antibody titers against Schmallenberg virus of 25 calves by age at sampling (based on 2–3 samplings per calf). There was a definite positive relationship (correlation coefficient: 0.73, significance level: < 0.01) between the VNT titer of the dam and the VNT titer of the corresponding calf (age ≤ 30 days) of 13 dam-calf combinations sampled on the same day (Figure 3): the higher the VNT titer of the dam, the higher the VNT titer (maternal antibodies) of the calf.
Figure 3

Relationship between virus neutralization test antibody titer (Log-scale) against Schmallenberg virus of calves and their dams (sampled the same day). Age of calves was ≤ 30 days.

Relationship between virus neutralization test antibody titer (Log-scale) against Schmallenberg virus of calves and their dams (sampled the same day). Age of calves was ≤ 30 days.

Conclusions

Our field data support the assumption that natural SBV infection in adult cows results in persistence of specific antibodies for at least two years. Based on the observed decay of maternally-derived antibodies in calves, it is presumed safe to vaccinate calves against SBV at an age of approximately 6months.

Methods

From all animals of a dairy herd in the eastern part of the Netherlands blood samples were taken five times in a 17-month period to be able to examine persistence and titers of neutralizing-antibodies against SBV over time in adult cattle and calves. Blood samples were obtained in the context of non-experimental clinical veterinary practices for diagnostic purposes and procedures followed were performed in accordance with the Dutch national as well as European Union animal experiment regulations. The dairy herd consisted of 60 milking cows, 50 heifers and calves; no animals from other herds were purchased onto the farm, a few older adult cows were sold including all the male calves born. This dairy herd is the only location in the Netherlands where Culicoides monitoring was executed continuously and where SBV RNA was detected in Culicoides caught in 2011 [8] and 2012 [9]. No SBV clinical signs were observed in any cattle of the dairy herd at the end of 2011 or the beginning of 2012. All animals of the herd were blood-sampled, for the first time on 19 April 2012 after retrospective detection of SBV RNA in the Culicoides collection caught in 2011 [8]. A total of three calves were stillborn during the one-year study period on this dairy, but all without the characteristic malformations observed after SBV infection, which was confirmed by gross pathology and all tissue samples of these calves tested SBV-negative by RT-PCR. Blood samples were tested for antibodies using a virus neutralization test (VNT) [12], with some small modifications: dilutions tested started at 1:4 and ended at 1:512. All samples were tested in duplicate. Titers were determined using the Reed-Münch method [13] and expressed on a 2Logarithm-scale. Distribution of VNT-titers by sampling date was summarized with a box and whisker plot [14] in Figure 2: the central line in the box plot indicates the median of the data, while the edges of the box indicate the first and third quartiles (that is, the 25th and 75th percentiles); extending from the box are whiskers, the top whisker expands to the 90th percentile and the bottom whisker to the 10th percentile; beyond the whiskers are observations that are relatively far from the median. All animals of the herd were again blood sampled on 17 September 2012 (5 months after 1st sampling), 9 December 2012 (8 months after 1st sampling), 23 April 2013 (12 months after 1st sampling) and 23 September 2013 (17 months after 1st sampling).

Competing interests

The authors declare they have no competing interests.

Authors’ contributions

AE designed the study, carried out the study in the field, performed the analysis and drafted the manuscript. WP contributed to the analysis of the data. NS carried out pathology on stillborn calves of the dairy herd. NS and WP commented on the draft manuscript. All authors read and approved the final manuscript.
  10 in total

1.  Detection and partial sequencing of Schmallenberg virus in cattle and sheep in Turkey.

Authors:  Huseyin Yilmaz; Bernd Hoffmann; Nuri Turan; Utku Y Cizmecigil; Juergen A Richt; Wim H M Van der Poel
Journal:  Vector Borne Zoonotic Dis       Date:  2014-02-27       Impact factor: 2.133

2.  Infection of white-tailed deer (Odocoileus virginianus) in Michigan with Jamestown Canyon virus (California serogroup) and the importance of maternal antibody in viral maintenance.

Authors:  P R Grimstad; D G Williams; S M Schmitt
Journal:  J Wildl Dis       Date:  1987-01       Impact factor: 1.535

3.  Duration of maternally derived antibodies against Akabane virus in calves: survival analysis.

Authors:  Toshiyuki Tsutsui; Takehisa Yamamoto; Yoko Hayama; Yasuhiro Akiba; Akiko Nishiguchi; Sota Kobayashi; Makoto Yamakawa
Journal:  J Vet Med Sci       Date:  2009-07       Impact factor: 1.267

4.  Schmallenberg Virus in Culicoides Biting Midges in the Netherlands in 2012.

Authors:  A R W Elbers; R Meiswinkel; E van Weezep; E A Kooi; W H M van der Poel
Journal:  Transbound Emerg Dis       Date:  2013-07-24       Impact factor: 5.005

5.  Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies.

Authors:  T G Kimman; F Westenbrink; B E Schreuder; P J Straver
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

6.  Long-term persistence of neutralising antibodies against bluetongue virus serotype 8 in naturally infected cattle.

Authors:  Michael Eschbaumer; Josef Eschweiler; Bernd Hoffmann
Journal:  Vaccine       Date:  2012-08-30       Impact factor: 3.641

7.  Development of a virus neutralisation test to detect antibodies against Schmallenberg virus and serological results in suspect and infected herds.

Authors:  Willie Loeffen; Sjaak Quak; Els de Boer-Luijtze; Marcel Hulst; Wim van der Poel; Ruth Bouwstra; Riks Maas
Journal:  Acta Vet Scand       Date:  2012-08-07       Impact factor: 1.695

8.  Colostral antibody induced interference of inactivated bluetongue serotype-8 vaccines in calves.

Authors:  Damien Vitour; Jean Guillotin; Corinne Sailleau; Cyril Viarouge; Alexandra Desprat; Frédéric Wolff; Guillaume Belbis; Benoit Durand; Labib Bakkali-Kassimi; Emmanuel Breard; Stéphan Zientara; Gina Zanella
Journal:  Vet Res       Date:  2011-02-02       Impact factor: 3.683

9.  Seroprevalence of Schmallenberg virus antibodies among dairy cattle, the Netherlands, winter 2011-2012.

Authors:  Armin R W Elbers; Willie L A Loeffen; Sjaak Quak; Els de Boer-Luijtze; Arco N van der Spek; Ruth Bouwstra; Riks Maas; Marcel A H Spierenburg; Eric P de Kluijver; Gerdien van Schaik; Wim H M van der Poel
Journal:  Emerg Infect Dis       Date:  2012-07       Impact factor: 6.883

10.  Schmallenberg virus in Culicoides spp. biting midges, the Netherlands, 2011.

Authors:  Armin R W Elbers; Rudy Meiswinkel; Erik van Weezep; Marianne M Sloet van Oldruitenborgh-Oosterbaan; Engbert A Kooi
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

  10 in total
  18 in total

1.  Generation and characterization of a potentially applicable Vero cell line constitutively expressing the Schmallenberg virus nucleocapsid protein.

Authors:  Yongning Zhang; Shaoqiang Wu; Shanshan Song; Jizhou Lv; Chunyan Feng; Xiangmei Lin
Journal:  Cytotechnology       Date:  2017-01-12       Impact factor: 2.058

2.  Cross-sectional study of Schmallenberg virus seroprevalence in wild ruminants in Poland at the end of the vector season of 2013.

Authors:  Magdalena Larska; Michał K Krzysiak; Julia Kęsik-Maliszewska; Jerzy Rola
Journal:  BMC Vet Res       Date:  2014-12-21       Impact factor: 2.741

3.  Seasonal drivers of the epidemiology of arthropod-borne viruses in Australia.

Authors:  Jemma L Geoghegan; Peter J Walker; Jean-Bernard Duchemin; Isabelle Jeanne; Edward C Holmes
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

4.  Early-life hepatitis e infection in pigs: the importance of maternally-derived antibodies.

Authors:  Mathieu Andraud; Maribel Casas; Nicole Pavio; Nicolas Rose
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

5.  Persistence of the protective immunity and kinetics of the isotype specific antibody response against the viral nucleocapsid protein after experimental Schmallenberg virus infection of sheep.

Authors:  Antoine Poskin; Stephanie Verite; Loic Comtet; Yves Van der Stede; Brigitte Cay; Nick De Regge
Journal:  Vet Res       Date:  2015-10-15       Impact factor: 3.683

6.  A freedom from disease study: Schmallenberg virus in the south of England in 2015.

Authors:  Jessica Eleanor Stokes; Matthew Baylis; Jennifer Sarah Duncan
Journal:  Vet Rec       Date:  2016-10-11       Impact factor: 2.695

7.  Monitoring of Schmallenberg virus in Spanish wild artiodactyls, 2006-2015.

Authors:  Ignacio García-Bocanegra; David Cano-Terriza; Gema Vidal; Rosa Rosell; Jorge Paniagua; Saúl Jiménez-Ruiz; Carlos Expósito; Antonio Rivero-Juarez; Antonio Arenas; Joan Pujols
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

8.  Post-epidemic Schmallenberg virus circulation: parallel bovine serological and Culicoides virological surveillance studies in Ireland.

Authors:  Á B Collins; D Barrett; M L Doherty; M Larska; J F Mee
Journal:  BMC Vet Res       Date:  2016-10-18       Impact factor: 2.741

9.  Exposure to Schmallenberg virus in Irish sheep in 2013.

Authors:  D J Barrett; S J More; R G O' Neill; D M Collins; C O'Keefe; V Regazzoli; D Sammin
Journal:  Vet Rec       Date:  2015-10-26       Impact factor: 2.695

10.  Monitoring for bovine arboviruses in the most southwestern islands in Japan between 1994 and 2014.

Authors:  Tomoko Kato; Tohru Yanase; Moemi Suzuki; Yoshito Katagiri; Kazufumi Ikemiyagi; Katsunori Takayoshi; Hiroaki Shirafuji; Seiichi Ohashi; Kazuo Yoshida; Makoto Yamakawa; Tomoyuki Tsuda
Journal:  BMC Vet Res       Date:  2016-06-24       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.